Pura Vida Investments, LLC Adma Biologics, Inc. Transaction History

Pura Vida Investments, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$2.47 - $3.88 $741,000 - $1.16 Million	300,000 New	300,000 $1.16 Million
Q4 2018 Feb 14, 2019	SELL	$2.17 - $6.12 $1.16 Million - $3.27 Million	-534,147 Reduced 93.49%	37,170 $89,000
Q3 2018 Nov 14, 2018	BUY	$4.39 - $6.85 $1.08 Million - $1.69 Million	246,317 Added 75.79%	571,317 $3.55 Million
Q2 2018 Aug 14, 2018	BUY	$4.39 - $5.44 $1.43 Million - $1.77 Million	325,000 New	325,000 $1.47 Million

265

178M

535K

21.2K

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.81B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.